CVS Health Co. (NYSE:CVS) Shares Sold by Vicus Capital

Vicus Capital lowered its stake in CVS Health Co. (NYSE:CVS) by 3.5% in the 3rd quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 4,981 shares of the pharmacy operator’s stock after selling 181 shares during the quarter. Vicus Capital’s holdings in CVS Health were worth $313,000 at the end of the most recent quarter.

Other institutional investors have also bought and sold shares of the company. Livelsberger Financial Advisory bought a new stake in CVS Health in the third quarter worth about $31,000. First Community Trust NA raised its position in CVS Health by 116.2% in the second quarter. First Community Trust NA now owns 562 shares of the pharmacy operator’s stock worth $33,000 after acquiring an additional 302 shares in the last quarter. Kathleen S. Wright Associates Inc. bought a new stake in CVS Health in the third quarter worth about $33,000. ORG Partners LLC raised its position in CVS Health by 11,840.0% in the second quarter. ORG Partners LLC now owns 597 shares of the pharmacy operator’s stock worth $35,000 after acquiring an additional 592 shares in the last quarter. Finally, Oliver Lagore Vanvalin Investment Group raised its position in CVS Health by 71.0% in the second quarter. Oliver Lagore Vanvalin Investment Group now owns 595 shares of the pharmacy operator’s stock worth $35,000 after acquiring an additional 247 shares in the last quarter. Institutional investors and hedge funds own 80.66% of the company’s stock.

Analysts Set New Price Targets

Several equities research analysts have commented on CVS shares. Royal Bank of Canada reiterated an “outperform” rating and issued a $68.00 price target on shares of CVS Health in a research report on Wednesday, September 4th. TD Cowen upgraded CVS Health from a “hold” rating to a “buy” rating and boosted their price objective for the stock from $59.00 to $85.00 in a report on Friday, October 4th. Deutsche Bank Aktiengesellschaft cut their price objective on CVS Health from $64.00 to $63.00 and set a “hold” rating on the stock in a report on Friday, August 9th. Truist Financial boosted their price objective on CVS Health from $66.00 to $76.00 and gave the stock a “buy” rating in a report on Friday, October 11th. Finally, Barclays upgraded CVS Health from an “equal weight” rating to an “overweight” rating and boosted their price objective for the stock from $63.00 to $82.00 in a report on Thursday, October 10th. Nine analysts have rated the stock with a hold rating and thirteen have assigned a buy rating to the company’s stock. According to MarketBeat, the company has a consensus rating of “Moderate Buy” and an average price target of $75.26.

CVS Health Trading Down 2.3 %

Shares of NYSE CVS opened at $56.85 on Wednesday. The stock has a market cap of $71.37 billion, a price-to-earnings ratio of 9.99, a PEG ratio of 0.93 and a beta of 0.54. The business has a 50 day simple moving average of $59.87 and a 200 day simple moving average of $60.19. CVS Health Co. has a 52 week low of $52.77 and a 52 week high of $83.25. The company has a debt-to-equity ratio of 0.83, a quick ratio of 0.66 and a current ratio of 0.86.

CVS Health (NYSE:CVS) last announced its quarterly earnings results on Wednesday, August 7th. The pharmacy operator reported $1.83 EPS for the quarter, beating the consensus estimate of $1.73 by $0.10. The business had revenue of $91.23 billion during the quarter, compared to analysts’ expectations of $91.41 billion. CVS Health had a return on equity of 12.72% and a net margin of 1.98%. The firm’s quarterly revenue was up 2.6% compared to the same quarter last year. During the same quarter in the previous year, the business posted $2.21 EPS. On average, research analysts predict that CVS Health Co. will post 6.51 earnings per share for the current fiscal year.

CVS Health Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Friday, November 1st. Shareholders of record on Monday, October 21st will be given a dividend of $0.665 per share. The ex-dividend date is Monday, October 21st. This represents a $2.66 dividend on an annualized basis and a yield of 4.68%. CVS Health’s payout ratio is currently 46.75%.

CVS Health Profile

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.